- Home
- CLFD vs LYEL Comparison
CLFD vs LYEL Comparison
Compare CLFD & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CLFD | LYEL |
|---|---|---|
| Founded | 1979 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 424.2M | 369.4M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | CLFD | LYEL |
|---|---|---|
| Price | $29.20 | $32.52 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $43.50 | $25.00 |
| AVG Volume (30 Days) | ★ 129.9K | 57.7K |
| Earning Date | 11-25-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $150,134,000.00 | $41,000.00 |
| Revenue This Year | $11.85 | N/A |
| Revenue Next Year | $23.09 | N/A |
| P/E Ratio | $65.87 | ★ N/A |
| Revenue Growth | ★ 19.56 | N/A |
| 52 Week Low | $23.78 | $7.65 |
| 52 Week High | $46.76 | $35.16 |
Technical Indicators
Market Signals| Indicator | CLFD | LYEL |
|---|---|---|
| Relative Strength Index (RSI) | 42.15 | 75.94 |
| Support Level | $27.67 | $20.59 |
| Resistance Level | $30.94 | $35.16 |
| Average True Range (ATR) | 1.53 | 2.56 |
| MACD | 0.30 | 1.05 |
| Stochastic Oscillator | 68.07 | 85.38 |
Price Performance
Historical ComparisonAbout CLFD Clearfield Inc.
Clearfield Inc designs, manufactures, and distributes fiber protection, fiber management, and fiber delivery solutions to enable rapid and cost-effective fiber-fed deployment throughout the broadband service provider space prominently across North America. Its 'fiber to anywhere' platform serves the requirements of Community Broadband customers, Multiple System Operators, Large Regional Service Providers, National Carriers, and International customers (including Europe, Canada, Mexico, and Caribbean Markets). Its product offerings include Accessories, Cassettes, Cable & Drop Assemblies, Frames & Panels, Microducts, Optical Components, etc. The company derives the majority of its revenue from the United States.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.